Live Breaking News & Updates on Pharmaceutical hazardous waste

Stay informed with the latest breaking news from Pharmaceutical hazardous waste on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Pharmaceutical hazardous waste and stay connected to the pulse of your community

Imexpharm aims for quality and affordability

Hanoi: “Vietnam is one of the fast-growing pharmaceutical markets in the world,” says Tran Thi Dao, general director of Imexpharm, adding that “after the Covid-19 pandemic, the country’s pharmaceutical industry still maintains growth momentum even though some other industries show signs of slowing down”.

Vietnam , Republic-of , Hanoi , Han-i , Viet-nam , Vietnam-institute-of-directors , European-union , Drug-administration-of-vietnam , Tran-thi-dao , Drug-administration , Vietnam-institute

pharmaceutical industry: Widespread use of industrial-grade excipients unearthed in Indian pharmaceutical manufacturing

India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has discovered the widespread use of industrial-grade excipients, unfit for human consumption, in the country's pharmaceutical manufacturing. Following international complaints, the CDSCO conducted investigations and inspections, revealing that unlicensed traders supplied industrial-grade gelatin, propylene glycol, and other excipients to pharmaceutical manufacturing units.

India , China , Drug-consultative-committee , Central-drugs-standard-control-organisation , Cosmetics-act , Pharmaceutical-industry , Ipa , Gelatin , Cdsco , Grade-gelatin , Pharmaceutical

Samsung Biologics surpasses 3 tril. won in annual orders for 1st time

Samsung Biologics has surpassed 3 trillion won ($2.3 billion) in accumulated annual orders with its contract development and manufacturing organization (CDMO) drug manufacturing business thanks to a recent large-scale contract with an Asia-based pharmaceutical company, according to the drugmaker, Tuesday.

Samsung-biologics , Baek-byung-yeul , Samsung-biologic-plant , Samsung-biologic , Plant , Company , Samsung , Pharmaceutical , Production , Won , Capacity

Bayer sees no quick fixes after bankers game out break-up

Company hired several teams of bankers for a strategy simulation game that studied various break-up scenarios

Germany , German , Team-blue , Team-red , Strategy , Simulation , Pharmaceutical , Organisation-bayer ,

Imexpharm raises its status with EU-GMP-standard factories

With the largest pharmaceutical production lines that meet European standards (EU-GMP) in Vietnam, Imexpharm has great potential to become an industry leader.

Binh-duong , Qu-ng-nam , Vietnam , Republic-of , Japan , Vietnamese , Sk-group-south-korea , Ministry-of-health , Drug-administration-of-vietnam , Imexpharm-corporation , Drug-administration

AstraZeneca To Exit India Manufacturing, Plans To Sell Its Lone Production Plant In Bengaluru

The company said it will sell the production facility as part of the ongoing strategic review of its global manufacturing and supply network.

Bengaluru , Karnataka , India , Bangalore , Chennai , Tamil-nadu , Astrazeneca , Novartis , Cipla , International-business-times , Astrazeneca-pharma-india-limited-company

Roche gives details of CHF1.2bn Basel site investment

The pharmaceutical giant has outlined its plan to invest CHF1.2 billion in its operations in Basel, Switzerland, including new R&D facilities.

Switzerland , Basel-roche , Gaetan-bally , Roche-basel-kaiseraugst , Institute-of-human-biology , Human-biology , Latest-news , Medical-research , Private-health-care , Research , Research-and-development , Pharmaceutical

Innovation And Healthcare Meet At Novartis

Novartis US executive Andrea Marazzi shares his view on innovation, healthcare challenges, and leadership amid the evolving landscape of medicine.

Milan , Lombardia , Italy , United-states , America , Stephanie-ricci , Andrea-marazzi , Novartis , North-america , Country-president , Novartis-canada , Commercial-strategy